Importance of quantitative analysis in the generation of insulin-expressing cells from human embryonic stem cells

Pancreas

Volumn 39, Issue 1, 2010, Pages 105-107

  Courtney, Monica L ^a,b   Jones, Peter M ^b   Burns, Christopher J ^a  

^a NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; CELL MARKER; HEPATOCYTE NUCLEAR FACTOR 1BETA; HEPATOCYTE NUCLEAR FACTOR 3BETA; INSULIN; MESSENGER RNA; NUCLEAR PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; RNA; TRANSCRIPTION FACTOR PDX 1; TRANSCRIPTION FACTOR SOX17;

CELL CULTURE; CELL DIFFERENTIATION; CELL LOSS; CELL MATURATION; CELL POPULATION; CELL PROLIFERATION; CELL SPECIFICITY; CELL STIMULATION; CELL STRUCTURE; CELL THERAPY; CELL TRANSDIFFERENTIATION; CELL TRANSPLANTATION; CELL TYPE; CONFOCAL MICROSCOPY; CYTOMETRY; DOWN REGULATION; EMBRYONIC STEM CELL; ENDOCRINE CELL; ENDODERM; GEL ELECTROPHORESIS; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENETIC SELECTION; HORMONE RELEASE; HUMAN; IMMUNOCYTOCHEMISTRY; IMMUNOFLUORESCENCE TEST; IMMUNOREACTIVITY; IN VITRO STUDY; IN VIVO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; LETTER; MONOLAYER CULTURE; ORGANOGENESIS; PANCREAS CELL; PANCREAS ISLET BETA CELL; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REGENERATIVE MEDICINE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENTIAL ANALYSIS; STIMULUS RESPONSE; SUBSTITUTION THERAPY; TREATMENT DURATION; UPREGULATION;

CELL DIFFERENTIATION; CYTOKINES; EMBRYONIC STEM CELLS; GENE EXPRESSION; HEPATOCYTE NUCLEAR FACTOR 3-BETA; HUMANS; IMMUNOHISTOCHEMISTRY; INSULIN-SECRETING CELLS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SOXF TRANSCRIPTION FACTORS; TIME FACTORS;

EID: 74049158251     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPA.0b013e3181b79d3c     Document Type: Letter

References (9)

1. Assady S, Maor G, Amit M, et al. Insulin production by human embryonic stem cells. Diabetes. 2001;50(8):1691-1697.
2. Raikwar SP, Zavazava NJ. Insulin producing cells derived from embryonic stem cells: are we there yet? J Cell Physiol. 2009; 218(2):256-263.
3. Jiang W, Deng H, Li D, et al. In vitro derivation of functional insulin-producing cells from human embryonic stem cells. Cell Res. 2007;17:333-344.
4. D'Amour KA, Bang AG, Eliazer S, et al. Production of pancreatic hormoneYexpressing endocrine cells from human embryonic stem cells. Nat Biotechnol. 2006;24(11): 1392-1401.
5. Kroon E, Martinson LA, Kadoya K, et al. Pancreatic endoderm derived from human embryonic stem cells generates glucose responsive insulin-secreting cells in vivo. Nat Biotechnol. 2008;26(4):443-452.
6. Guo Y, Costa R, Ramsey H, et al. The embryonic stem cell transcription factors Oct-4 and FoxD3 interact to regulate endodermal-specific promoter expression. Proc Natl Acad Sci U S A. 2002;99(6): 3663-3667.
7. Seguin CA, Draper JS, Nagy A, et al. Establishment of endoderm progenitors by SOX transcription factor expression in human embryonic stem cells. Cell Stem Cell. 2008; 3:182-195.
8. Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007;131:861-872.
9. Yu J, Vodyanik MA, Smuga-Otto K, et al. Induced pluripotent stem cell lines derived from human somatic cells. Science. 2007; 318:1917-1920.